Vysioneer is a leader in AI technology solutions for life science and healthcare. The mission is to conquer cancer through AI-powered precision tumor tracking along the patient journey. Vysioneer's flagship product is the world's first FDA-cleared tumor auto-contouring platform, which unlocks real-world guideline-based tumor response assessment. The platform enables pharma companies to accelerate cancer drug approval and reduce clinical trial costs. For physicians and patients, the platform increases the visibility on treatment efficacy to enhance informed treatment decisions.